These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26018865)

  • 1. Venom immunotherapy: clinical efficacy, safety and contraindications.
    Kosnik M; Korosec P
    Expert Rev Clin Immunol; 2015; 11(8):877-84. PubMed ID: 26018865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy and biologicals for the treatment of allergy to Hymenoptera stings.
    Ridolo E; Pellicelli I; Kihlgren P; Nizi MC; Pucciarini F; Senna G; Incorvaia C
    Expert Opin Biol Ther; 2019 Sep; 19(9):919-925. PubMed ID: 31190572
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological and clinical factors associated with adverse systemic reactions during the build-up phase of honeybee venom immunotherapy.
    Korošec P; Žiberna K; Šilar M; Dežman M; Čelesnik Smodiš N; Rijavec M; Kopač P; Eržen R; Lalek N; Bajrović N; Košnik M; Zidarn M
    Clin Exp Allergy; 2015 Oct; 45(10):1579-89. PubMed ID: 26046807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming severe adverse reactions to venom immunotherapy using anti-IgE antibodies in combination with a high maintenance dose.
    Stretz E; Oppel EM; Räwer HC; Chatelain R; Mastnik S; Przybilla B; Ruëff F
    Clin Exp Allergy; 2017 Dec; 47(12):1631-1639. PubMed ID: 28802075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft für Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association of German Allergologists (AeDA), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Allergy and Environmental Medicine (GPA), German Respiratory Society (DGP), and the Austrian Society for Allergy and Immunology (ÖGAI).
    Ruëff F; Bauer A; Becker S; Brehler R; Brockow K; Chaker AM; Darsow U; Fischer J; Fuchs T; Gerstlauer M; Gernert S; Hamelmann E; Hötzenecker W; Klimek L; Lange L; Merk H; Mülleneisen NK; Neustädter I; Pfützner W; Sieber W; Sitter H; Skudlik C; Treudler R; Wedi B; Wöhrl S; Worm M; Jakob T
    Allergol Select; 2023; 7():154-190. PubMed ID: 37854067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of clinical effectiveness of Hymenoptera venom immunotherapy.
    Ruëff F; Vos B; Oude Elberink J; Bender A; Chatelain R; Dugas-Breit S; Horny HP; Küchenhoff H; Linhardt A; Mastnik S; Sotlar K; Stretz E; Vollrath R; Przybilla B; Flaig M
    Clin Exp Allergy; 2014; 44(5):736-46. PubMed ID: 24447114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase.
    Ruëff F; Przybilla B; Biló MB; Müller U; Scheipl F; Aberer W; Birnbaum J; Bodzenta-Lukaszyk A; Bonifazi F; Bucher C; Campi P; Darsow U; Egger C; Haeberli G; Hawranek T; Kucharewicz I; Küchenhoff H; Lang R; Quercia O; Reider N; Severino M; Sticherling M; Sturm GJ; Wüthrich B;
    J Allergy Clin Immunol; 2010 Jul; 126(1):105-11.e5. PubMed ID: 20542320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of immunotherapy to wasp and bee venom.
    Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA
    Clin Exp Allergy; 2011 Sep; 41(9):1226-34. PubMed ID: 21729181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected.
    Bonadonna P; Zanotti R; Pagani M; Bonifacio M; Scaffidi L; Olivieri E; Franchini M; Reccardini F; Costantino MT; Roncallo C; Mauro M; Boni E; Rizzini FL; Bilò MB; Marcarelli AR; Passalacqua G
    J Allergy Clin Immunol Pract; 2018; 6(4):1368-1372. PubMed ID: 29258788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Safety Profiles of 3 Different Hymenoptera Venom Immunotherapy Protocols: A Retrospective 2-Center Study of 143 Patients.
    Pospischil IM; Kagerer M; Cozzio A; Angelova-Fischer I; Guenova E; Ballmer-Weber B; Hoetzenecker W
    Int Arch Allergy Immunol; 2020; 181(10):783-789. PubMed ID: 32781451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical aspects of hymenoptera venom allergy and venom immunotherapy.
    Bilò MB; Tontini C; Martini M; Corsi A; Agolini S; Antonicelli L
    Eur Ann Allergy Clin Immunol; 2019 Nov; 51(6):244-258. PubMed ID: 31594296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin Test Reactivity to Hymenoptera Venom after Venom Immunotherapy Correlates Inversely with the IgG/IgE Ratio.
    Saulite I; Hoetzenecker W; Guenova E; Schmid-Grendelmeier P; Glatz M
    Int Arch Allergy Immunol; 2017; 174(3-4):190-199. PubMed ID: 29130986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venom immunotherapy in patients with allergic reactions to insect stings.
    Incorvaia C; Mauro M; Gritti BL; Makri E; Ridolo E
    Expert Rev Clin Immunol; 2018 Jan; 14(1):53-59. PubMed ID: 29202591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in the diagnosis and treatment of hymenoptera venom allergy.
    Müller UR
    Int Arch Allergy Immunol; 2001 Apr; 124(4):447-53. PubMed ID: 11340327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory markers of mast cell and basophil activation in monitoring rush immunotherapy in bee venom-allergic children.
    Cichocka-Jarosz E; Dorynska A; Pietrzyk JJ; Spiewak R
    Immunotherapy; 2011 Aug; 3(8):1013-7. PubMed ID: 21843104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerability during build-up phase of a rush venom immunotherapy.
    Bernkopf K; Rönsch H; Spornraft-Ragaller P; Neumeister V; Bauer A
    Ann Allergy Asthma Immunol; 2016 Apr; 116(4):360-5. PubMed ID: 27055991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High sensitivity of basophils predicts side-effects in venom immunotherapy.
    Kosnik M; Silar M; Bajrovic N; Music E; Korosec P
    Allergy; 2005 Nov; 60(11):1401-6. PubMed ID: 16197472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
    Ruëff F; Wenderoth A; Przybilla B
    J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.